Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

A niche play for stem cells

January 22, 2009 8:00 AM UTC

Aggressive hematologic malignancies like acute lymphoblastic leukemia can blight the bone marrow and severely hamper the growth of healthy blood cells. Indeed, following chemotherapy, even the presence of a few leukemic cells can prevent bone marrow transplants from taking hold, thus impairing resumption of normal hematopoiesis.

A paper by a University of Chicagoteam now shows how leukemic cells impair normal hematopoiesis by reprogramming the hematopoietic stem (HS) cell niche, a specialized region at the edge of the bone marrow. The researchers suggest that inhibiting a tumor-secreted protein that lures HS cells toward these diseased niches could help in bone marrow transplantation and recovery from cancer.1...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article